Lasofoxifene: a new-generation SERM for the treatment of postmenopausal osteoporosis

By Gennari Luigi   Merlotti Daniela   Nuti Ranuccio  

Expert Review of Obstretrics and Gynecology, Vol. 4, Iss. 6, 2009-11 ,pp. : 607-617

Informa Healthcare

Access to resources Recommend Favorite

Relationship between serum leptin concentrations and bone mineral density as well as biochemical markers of bone turnover in women with postmenopausal osteoporosis

By Shaarawy M.   Abassi A.F.   Hassan H.   Salem M.E.  

Fertility and Sterility, Vol. 79, Iss. 4, 2003-04 ,pp. : 919-924

Elsevier

Access to resources Recommend Favorite

Androgen receptor (AR) gene microsatellite polymorphism in postmenopausal women: correlation to bone mineral density and susceptibility to osteoporosis

By Chen H.-Y.   Chen W.-C.   Wu M.-C.   Tsai F.-J.   Tsai C.-H.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 107, Iss. 1, 2003-03 ,pp. : 52-56

Elsevier

Access to resources Recommend Favorite

Postmenopausal Osteoporosis: Hormones and other therapies

By Purdie David  

Climacteric, Vol. 9, Iss. 4, 2006-08 ,pp. : 320-320

Informa Healthcare

Access to resources Recommend Favorite

Hormone replacement as the first-line prevention for postmenopausal osteoporosis

By Alexandersen Peter   Karsdal Morten A   Christiansen Claus  

Expert Review of Obstretrics and Gynecology, Vol. 2, Iss. 5, 2007-09 ,pp. : 689-700

Informa Healthcare

Access to resources Recommend Favorite